Problem statement: Answer the multiple-choice question.
Question: Which drug has a -18.390% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. CCN(Cc1cnn(C)c1)C(=O)c1cc(COc2ccc3c(c2)CCCC3)on1
b. COc1cccc(C(=O)NC2C(=O)N3C(C(=O)O)=C(COC(C)=O)CSC23)c1
Answer: a. CCN(Cc1cnn(C)c1)C(=O)c1cc(COc2ccc3c(c2)CCCC3)on1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(Cc1cnn(C)c1)C(=O)c1cc(COc2ccc3c(c2)CCCC3)on1
CCN(Cc1cnn(C)c1)C(=O)c1cc(COc2ccc3c(c2)CCCC3)on1
N-ethyl-N-[(1-methylpyrazol-4-yl)methyl]-5-(5,6,7,8-tetrahydronaphthalen-2-yloxymethyl)-1,2-oxazole-3-carboxamide